US 10316318
Oligonucleotide compositions and uses thereof
granted A61PA61P35/00A61P35/02
Quick answer
US patent 10316318 (Oligonucleotide compositions and uses thereof) held by MIRAGEN THERAPEUTICS, INC. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00